Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
3,461,617
-
Shares change
-
+183,352
-
Total reported value, excl. options
-
$35,024,345
-
Value change
-
+$1,328,410
-
Put/Call ratio
-
2.34%
-
Number of buys
-
27
-
Number of sells
-
-13
-
Price
-
$10.12
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q4 2016
53 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q4 2016.
XBiotech Inc. - Common Shares, no par value (XBIT) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,461,617 shares
of 33,289,095 outstanding shares and own 10.4% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (1,013,917 shares), VANGUARD GROUP INC (710,277 shares), STATE STREET CORP (285,898 shares), BlackRock Institutional Trust Company, N.A. (216,051 shares), NORTHERN TRUST CORP (209,452 shares), GEODE CAPITAL MANAGEMENT, LLC (145,252 shares), GOLDMAN SACHS GROUP INC (74,365 shares), Bank of New York Mellon Corp (72,505 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (68,231 shares), and BlackRock Investment Management, LLC (67,378 shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.